The FDA has approved Cymbalta for the management of fibromyalgia – almost exactly one year after Lyrica received the distinction of being the first drug ever approved to treatment this painful and often debilitating illness.
Lyrica's approval gave legitimacy to fibromyalgia in the minds of many who questioned whether it was a real disease. The approval of a second medication for FM can only add to its credibility. It also gives physicians more options for treating FM patients, thereby increasing the number of doctors who are willing to try.
To learn more about Cymbalta, its use for fibromyalgia, and research findings, read "Cymbalta Approved for Fibromyalgia."
